Skip to main content

Articles By Jack Cush, MD

research2.jpg

Arthritis Foundation Awards $5.5 Million to 11 Investigators

The Arthritis Foundation announced that 11 scientists were selected out of 167 proposals as the 2015 Scientific Discovery Awardees for their innovations toward finding a cure for arthritis and related diseases.

Read Article
Lupusfoto.jpg

Young Lupus Patients Have Higher Mortality Risk

A retrospective study examined mortality rates by comparing 2740 UK lupus patients  who were matched 1:4 with controls from the UK Clinical Practice Research Datalink between 1999 and 2012. (Citation source http://buff.ly/1nJWKIT)

Read Article
vaccine.jpg

Should You Avoid Pneumococcal Vaccine in CAPS and Behcet's Patients

Althought EULAR currently recommends the pneumococcal vaccine be given to patients with inflammatory rheumatic diseases and the Centers for Disease Control and Prevention (CDC) recommends the vaccine in patients treated with immunosuppressive drugs, a recent brief report suggests it be

Read Article
pregnant_0.jpg

Increased Congenital Anomalies in Children from Women with a Juvenile Arthritis History

A Quebec administrative claims analysis examined the birth outcomes of women with a history of juvenile idiopathic arthritis (JIA) who subsequently had a first-time birth (between 1983-2010).

Read Article
Piles.paper_.jpg

Cochrane Review:NSAIDs Equally Effective for Axial Spondyloarthritis

Until the advent of TNF inhibitor therapy, nonsteroidal antiinflammatory drugs (NSAIDs) were the only effective treatment for ankylosing spondylitis or spondyloarthritis (SpA).  More recently, several reports have suggested clinical and radiographic benefits to sustained NSAID use.

Read Article
cancer.melanoma.jpg

Rheumatoid Arthritis, TNF inhibitors and the Risk of Skin Cancer

Rheumatoid arthritis (RA) patients are said to have a neutral risk for neoplasia, but this is because they have a lower risk of colon cancer and breast cancer but a higher risk of lung cancer, lymphoma and skin cancers.

Read Article
lab-36522_640.png

High 14-3-3η Levels Have Predictive Value in Early Inflammatory Arthritis

14-3-3η is a new serum assay that has utility in diagnosing and treating patients with rheumatoid arthritis (RA) and early inflammatory arthritis (EIA).

Read Article
puzzle.RA_.jpg

It Took Me 30 Years to Learn This About Rheumatoid Arthritis

I’m alot better at RA in the last 10 years than I was when I started to practice 30 years ago. RA has not changed, but tools, knowledge and treatments have progressed admirably. Decades have taught me that many aspects of RA were wrongly taught, misunderstood or not apparent when I first started in rheumatology in 1984. Here are 10 things I've learned.

Read Article
networking.jpg

Comorbidities Start Early in Rheumatoid Arthritis

A Northern Sweden early rheumatoid arthritis (RA) cohort of 950 patients was enrolled starting in 1995. A validated questionnaire at RA onset (T0) and after 5 years (T5) after enrollment. Currently, 726 of these have had RA for ≥5 years.

Read Article
TNFinhib.jpg

No Significant Increased Risk with TNF Inhibitors During Pregnancy

A population-based study of 1,272,424 live-born infants from Denmark and Sweden examined the prevalence of birth defects among infants born to 683 women with chronic inflammatory disease (inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or psoriasis)

Read Article
×